TYRA 8-K: SEC filing

Tyra Biosciences

Filed with the SEC on Nov 10, 2026 · accession 0001193125-26-454474

TYRA filed a 8-K (current report) with the SEC on Nov 10, 2026. A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Summary of the filing

Tyra Biosciences issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

For details, click here →How to read a 8-K →

Key details

RegistrantTyra Biosciences, Inc.

Chief financial officerAlan Fuhrman

✦ Ask GOAX AI about this filing — what it means for TYRA, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for TYRA?

Click here

Frequently asked questions

What did TYRA file with the SEC on Nov 10, 2026?

TYRA filed a 8-K (SEC filing). Tyra Biosciences issued a press release announcing its financial results for the quarter ended September 30, 2026, furnished under Item 2.02 of Form 8-K.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other TYRA SEC filings

Get alerts when TYRA files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

TYRA overview TYRA analysis TYRA news Latest SEC filings